These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8059803)

  • 1. Secondary bacterial infections in HIV-infected patients: an alternative ambulatory outpatient treatment utilizing intravenous cefotaxime.
    Morales JO; Von Behren L
    Am J Med; 1994 Aug; 97(2A):9-13. PubMed ID: 8059803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outpatient antibiotic therapy for elderly patients. HIAT Study Group.
    Angel JV
    Am J Med; 1994 Aug; 97(2A):43-9. PubMed ID: 8059801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of skin and soft-tissue infections utilizing an outpatient parenteral drug delivery device: a multicenter trial. HIAT Study Group.
    Poretz DM
    Am J Med; 1994 Aug; 97(2A):23-7. PubMed ID: 8059797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of intravenous cefotaxime for treating pneumonia in outpatients.
    Morales JO; Snead H
    Am J Med; 1994 Aug; 97(2A):28-33. PubMed ID: 8059798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of serious infections with cefotaxime utilizing an outpatient drug delivery device: global analysis of a large-scale, multicenter trial. HIAT Study Group.
    Poretz DM
    Am J Med; 1994 Aug; 97(2A):34-42. PubMed ID: 8059800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of bone and joint infections utilizing a third-generation cephalosporin with an outpatient drug delivery device. HIAT Study Group.
    Mauceri AA
    Am J Med; 1994 Aug; 97(2A):14-22. PubMed ID: 8059796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing costs and hospital stay for pneumonia with home intravenous cefotaxime treatment: results with a computerized ambulatory drug delivery system.
    Williams DN
    Am J Med; 1994 Aug; 97(2A):50-5. PubMed ID: 8059802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral ciprofloxacin vs parenteral cefotaxime in the treatment of difficult skin and skin structure infections. A multicenter trial.
    Gentry LO; Ramirez-Ronda CH; Rodriguez-Noriega E; Thadepalli H; del Rosal PL; Ramirez C
    Arch Intern Med; 1989 Nov; 149(11):2579-83. PubMed ID: 2684078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Once-daily therapy with ceftriaxone compared with daily multiple-dose therapy with cefotaxime for serious bacterial infections: a randomized, double-blind study.
    Mandell LA; Bergeron MG; Ronald AR; Vega C; Harding G; Saginur R; Feld R; Duperval R; Landis SJ; Miedzinski LJ
    J Infect Dis; 1989 Sep; 160(3):433-41. PubMed ID: 2668427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic treatment of cutaneous infections. A comparative study of ciprofloxacin and cefotaxime.
    Parish LC; Asper R
    Am J Med; 1987 Apr; 82(4A):227-9. PubMed ID: 3555041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative evaluation of cefmenoxime versus cefoxitin in serious infections.
    Bechard DL; Hawkins SH; Sutherland SC
    Am J Med; 1984 Dec; 77(6A):13-6. PubMed ID: 6097117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative evaluation of oral ofloxacin versus intravenous cefotaxime therapy for serious skin and skin structure infections.
    Gentry LO; Rodriguez-Gomez G; Zeluff BJ; Khoshdel A; Price M
    Am J Med; 1989 Dec; 87(6C):57S-60S. PubMed ID: 2690621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety, efficacy, and cost savings in an outpatient intravenous antibiotic program.
    Williams DN; Bosch D; Boots J; Schneider J
    Clin Ther; 1993; 15(1):169-79; discussion 168. PubMed ID: 8458046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative, double-blind study of oral ciprofloxacin and intravenous cefotaxime in skin and skin structure infections.
    Ramirez-Ronda CH; Saavedra S; Rivera-Vázquez CR
    Am J Med; 1987 Apr; 82(4A):220-3. PubMed ID: 3555040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind comparison of ciprofloxacin with cefotaxime in the treatment of skin and skin structure infections.
    Pérez-Ruvalcaba JA; Quintero-Pérez NP; Morales-Reyes JJ; Huitrón-Ramírez JA; Rodríguez-Chagollán JJ; Rodríguez-Noriega E
    Am J Med; 1987 Apr; 82(4A):242-6. PubMed ID: 3555042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical studies of cefotaxime in infections in internal medicine].
    Kawasaki H; Suou T; Watanabe K; Yoshida K; Sasaki H; Kishimoto Y; Sugihara T; Ishitobi S; Kanno S; Tsuruhara I
    Jpn J Antibiot; 1984 Sep; 37(9):1714-28. PubMed ID: 6096586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of intravenous cefotaxime therapy in neonates].
    Nakazawa S; Sato H; Hirama Y; Chikaoka H
    Jpn J Antibiot; 1982 Jul; 35(7):1761-6. PubMed ID: 6294357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulbactam/cefoperazone versus cefotaxime for the treatment of moderate-to-severe bacterial infections: results of a randomized, controlled clinical trial.
    Li JT; Lu Y; Hou J; Chen YF; Miao JZ; Jia YX; Hou J; Zhang XZ; Chen DK; Hu WZ; Li LJ; Liu DM; Wang Z; Wu J; Gu JM; Wang HL; Zhang YL; Sun L
    Clin Infect Dis; 1997 Mar; 24(3):498-505. PubMed ID: 9114206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Second- and Third-Generation Cephalosporin as Initial Therapy for Women with Community-Onset Uncomplicated Acute Pyelonephritis.
    Chang UI; Kim HW; Wie SH
    Yonsei Med J; 2015 Sep; 56(5):1266-73. PubMed ID: 26256969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceftizoxime vs. cefotaxime--a comparative randomized multicenter study.
    Segev S; Kitzes R; Rubinstein E; Pitlik S; Samra Y; Shenkman L; Weinberg M
    Isr J Med Sci; 1988 Aug; 24(8):410-4. PubMed ID: 3045049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.